WebNational Center for Biotechnology Information WebWe evaluated the impact of low hemoglobin (Hb) levels, measured at different time points, on a consecutive cohort of patients with locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) who underwent …
Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV …
WebFeb 16, 2016 · head and neck cancer; nephrotoxicity; chemoradiotherapy; cisplatin 1. Introduction Concurrent chemo - radiotherapy (CCRT) is the standard of care for unresectable locally advanced head and neck squamous cell cancer (HNSCC), organ preservation, positive surgical margins, and/or lymph node involvement with extra - … WebApr 12, 2024 · Materials & methods: Disease-free survival and overall survival were compared according to cervical computed tomography for radiotherapy in 123 sarcopenic and non-sarcopenic patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiotherapy with weekly cisplatin. read woke south ayrshire primaries
Weekly Cisplatin Plus Radiation for Postoperative Head and Neck …
WebCisplatin (Platinol ®) is the standard chemotherapy drug that doctors use for head and neck cancer chemoradiation. Your doctor may recommend a different drug therapy that is equally effective based on which side effects are easier for you to tolerate. WebMar 1, 2024 · Key Objective. Chemoradiotherapy with 3-weekly cisplatin at a dose of 100 mg/m 2 is the standard treatment for patients with postoperative locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) with high risk for … Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer. … WebIn this randomized trial of the postoperative treatment of high-risk squamous-cell carcinoma of the head and neck, concurrent radiotherapy plus chemotherapy (cisplatin) reduced the incidence of loc... read wo neng fu zhi tian fu